163 related articles for article (PubMed ID: 37815735)
41. Recent increase in enterococci, viridans streptococci, Pseudomonas spp. and multiresistant strains among haematological patients, with a negative impact on outcome. Results of a 3-year surveillance study at a single institution.
Cattaneo C; Casari S; Bracchi F; Signorini L; Ravizzola G; Borlenghi E; Re A; Manca N; Carosi G; Rossi G
Scand J Infect Dis; 2010 May; 42(5):324-32. PubMed ID: 20100118
[TBL] [Abstract][Full Text] [Related]
42. Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
Chong PP; van Duin D; Bangdiwala A; Ivanova A; Miller WC; Weber DJ; Gilligan PH; Shea TC
Clin Ther; 2016 Nov; 38(11):2468-2476. PubMed ID: 27771176
[TBL] [Abstract][Full Text] [Related]
43. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis.
Cherif H; Kronvall G; Björkholm M; Kalin M
Hematol J; 2003; 4(6):420-6. PubMed ID: 14671614
[TBL] [Abstract][Full Text] [Related]
44. Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis.
Wang J; Zhang H; Yan J; Zhang T
J Matern Fetal Neonatal Med; 2022 Mar; 35(5):861-870. PubMed ID: 32102584
[TBL] [Abstract][Full Text] [Related]
45. Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting.
Xie O; Slavin MA; Teh BW; Bajel A; Douglas AP; Worth LJ
BMC Infect Dis; 2020 Mar; 20(1):228. PubMed ID: 32188401
[TBL] [Abstract][Full Text] [Related]
46. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
47. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.
Wisplinghoff H; Reinert RR; Cornely O; Seifert H
J Clin Microbiol; 1999 Jun; 37(6):1876-80. PubMed ID: 10325340
[TBL] [Abstract][Full Text] [Related]
48. Bloodstream Infections in Patients with Hematologic Diseases: Causative Organisms and Factors Associated with Resistance.
Choi H; Ahn H; Lee R; Cho SY; Lee DG
Infect Chemother; 2022 Jun; 54(2):340-352. PubMed ID: 35794719
[TBL] [Abstract][Full Text] [Related]
49. Bacterial bloodstream infections and patterns of resistance in patients with haematological malignancies at a tertiary centre in Lebanon over 10 years.
Haddad S; Jabbour JF; Hindy JR; Makki M; Sabbagh A; Nayfeh M; Boustany M; El-Zein S; Tamim H; Zakhem AE; El Cheikh J; Bazarbachi A; Kanj SS
J Glob Antimicrob Resist; 2021 Dec; 27():228-235. PubMed ID: 34607062
[TBL] [Abstract][Full Text] [Related]
50. The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program.
Diekema DJ; Hsueh PR; Mendes RE; Pfaller MA; Rolston KV; Sader HS; Jones RN
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010862
[TBL] [Abstract][Full Text] [Related]
51. Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study.
Irfan S; Idrees F; Mehraj V; Habib F; Adil S; Hasan R
BMC Infect Dis; 2008 Jun; 8():80. PubMed ID: 18541017
[TBL] [Abstract][Full Text] [Related]
52. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients.
Poutsiaka DD; Skiffington S; Miller KB; Hadley S; Snydman DR
J Infect; 2007 Jun; 54(6):567-71. PubMed ID: 17188750
[TBL] [Abstract][Full Text] [Related]
53. Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
Kim SH; Kwon JC; Choi SM; Lee DG; Park SH; Choi JH; Yoo JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
Ann Hematol; 2013 Apr; 92(4):533-41. PubMed ID: 23161391
[TBL] [Abstract][Full Text] [Related]
54. Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience.
Radocha J; Paterová P; Zavřelová A; Víšek B; Gabalec F; Žemličková H; Žák P
Folia Microbiol (Praha); 2018 Mar; 63(2):141-146. PubMed ID: 28776170
[TBL] [Abstract][Full Text] [Related]
55. Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.
Kleinhendler E; Cohen MJ; Moses AE; Paltiel O; Strahilevitz J; Cahan A
Int J Antimicrob Agents; 2018 Jan; 51(1):71-76. PubMed ID: 28705670
[TBL] [Abstract][Full Text] [Related]
56. Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance.
Schelenz S; Nwaka D; Hunter PR
J Antimicrob Chemother; 2013 Jun; 68(6):1431-8. PubMed ID: 23396855
[TBL] [Abstract][Full Text] [Related]
57. Resistance to empirical β-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study.
Chumbita M; Puerta-Alcalde P; Yáñez L; Cuesta MA; Chinea A; Español Morales I; Fernández Abellán P; Gudiol C; Guerreiro M; González-Sierra P; Rojas R; Sánchez Pina JM; Sánchez Vadillo I; Varela R; Vázquez L; Lopera C; Monzó P; Garcia-Vidal C
J Antimicrob Chemother; 2022 Jun; 77(7):2017-2023. PubMed ID: 35466357
[TBL] [Abstract][Full Text] [Related]
58. Characterising health care-associated bloodstream infections in public hospitals in Queensland, 2008-2012.
Si D; Runnegar N; Marquess J; Rajmokan M; Playford EG
Med J Aust; 2016 Apr; 204(7):276. PubMed ID: 27078605
[TBL] [Abstract][Full Text] [Related]
59. Evaluating antimicrobial duration for Gram-negative bacteremia in patients with neutropenia due to hematologic malignancy or hematopoietic stem cell transplantation.
Ranganath N; Yetmar ZA; McCandless AR; Rivera CG; Lahr BD; Tande AJ; Shah AS
Transpl Infect Dis; 2023 Oct; 25(5):e14085. PubMed ID: 37279240
[TBL] [Abstract][Full Text] [Related]
60. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).
Biedenbach DJ; Moet GJ; Jones RN
Diagn Microbiol Infect Dis; 2004 Sep; 50(1):59-69. PubMed ID: 15380279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
